Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Lybeck

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Frontiers in Oncology|February 13, 2015
The war on cancer: a military perspectiveBryan Oronsky, Corey A Carter, Vernon Mackie, et al.
Translational Oncology|April 27, 2018
A Review of Clinical Radioprotection and Chemoprotection for Oral MucositisBryan Oronsky, Sharad Goyal, Michelle M Kim, et al.
Neoplasia (New York, N.Y.)|October 18, 2015
Confirmatory Trials in the Evaluation of Anticancer Medicinal Products in Man--PFS2: A Measure of Therapeutic Action-At-A-DistanceBryan Oronsky, Corey A Carter, Tony R Reid, et al.
Medical Oncology (Northwood, London, England)|July 6, 2016
Targeting tumor hypoxia with the epigenetic anticancer agent, RRx-001: a superagonist of nitric oxide generationMarcel H Fens, Pedro Cabrales, Jan Scicinski, et al.
Case Reports in Oncology|May 18, 2017
A Case of Paraneoplastic Cushing Syndrome Presenting as Hyperglycemic Hyperosmolar Nonketotic SyndromeChristina E Brzezniak, Nicole Vietor, Patricia E Hogan, et al.
Oncoimmunology|November 11, 2017
No patient left behind: The promise of immune priming with epigenetic agentsCorey A Carter, Bryan T Oronsky, Joseph Roswarski, et al.
Journal of Medicinal Chemistry|May 27, 2021
Discovery of RRx-001, a Myc and CD47 Downregulating Small Molecule with Tumor Targeted Cytotoxicity and Healthy Tissue Cytoprotective Properties in Clinical DevelopmentBryan Oronsky, XiaoNing Guo, XiaoHui Wang, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|August 23, 2020
COVID-19 and cancer: A guide with suggested COVID-19 rule-out criteria to support clinical decision-makingChristopher Larson, Bryan Oronsky, Sharad Goyal, et al.
Biomolecules|July 8, 2016
Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming AgentsBryan Oronsky, Jan Scicinski, Michelle M Kim, et al.
Frontiers in Oncology|July 1, 2015
Episensitization: Defying Time's ArrowBryan T Oronsky, Arnold L Oronsky, Michelle Lybeck, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Frontiers in Oncology|February 13, 2015
The war on cancer: a military perspectiveBryan Oronsky, Corey A Carter, Vernon Mackie, et al.
Translational Oncology|April 27, 2018
A Review of Clinical Radioprotection and Chemoprotection for Oral MucositisBryan Oronsky, Sharad Goyal, Michelle M Kim, et al.
Neoplasia (New York, N.Y.)|October 18, 2015
Confirmatory Trials in the Evaluation of Anticancer Medicinal Products in Man--PFS2: A Measure of Therapeutic Action-At-A-DistanceBryan Oronsky, Corey A Carter, Tony R Reid, et al.
Medical Oncology (Northwood, London, England)|July 6, 2016
Targeting tumor hypoxia with the epigenetic anticancer agent, RRx-001: a superagonist of nitric oxide generationMarcel H Fens, Pedro Cabrales, Jan Scicinski, et al.
Case Reports in Oncology|May 18, 2017
A Case of Paraneoplastic Cushing Syndrome Presenting as Hyperglycemic Hyperosmolar Nonketotic SyndromeChristina E Brzezniak, Nicole Vietor, Patricia E Hogan, et al.
Oncoimmunology|November 11, 2017
No patient left behind: The promise of immune priming with epigenetic agentsCorey A Carter, Bryan T Oronsky, Joseph Roswarski, et al.
Journal of Medicinal Chemistry|May 27, 2021
Discovery of RRx-001, a Myc and CD47 Downregulating Small Molecule with Tumor Targeted Cytotoxicity and Healthy Tissue Cytoprotective Properties in Clinical DevelopmentBryan Oronsky, XiaoNing Guo, XiaoHui Wang, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|August 23, 2020
COVID-19 and cancer: A guide with suggested COVID-19 rule-out criteria to support clinical decision-makingChristopher Larson, Bryan Oronsky, Sharad Goyal, et al.
Biomolecules|July 8, 2016
Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming AgentsBryan Oronsky, Jan Scicinski, Michelle M Kim, et al.
Frontiers in Oncology|July 1, 2015
Episensitization: Defying Time's ArrowBryan T Oronsky, Arnold L Oronsky, Michelle Lybeck, et al.
Pageof 3